Keyu is a Regulatory Scientist at Blue Frog Scientific, specialising in EU and UK chemical regulatory compliance, with particular expertise in REACH. Since the beginning of her regulatory career, Keyu has focused on supporting clients with complex registration and compliance requirements under the EU and UK REACH frameworks. She is experienced in independently leading regulatory projects and efficiently delivering registration strategies, dossier preparation, and submission, including the establishment and management of Only Representative frameworks.
Keyu has managed many client projects, the majority of which involve regulatory affairs activities. In addition to her technical role, she serves as a client manager, taking overall responsibility for project coordination, ensuring proactive communication, and delivering high-quality regulatory support aligned with client and regulatory expectations. Her technical expertise includes preparation and submission of IUCLID dossiers, authoring study summaries and weight-of-evidence assessments, regulatory strategy development, and classification and labelling documentation. She also contributes to the preparation of robust (Q)SAR Prediction Reporting Formats (QPRFs), supported by mechanistic understanding and mode-of-action frameworks where relevant.
Keyu is developing advanced computational toxicology and ecotoxicology skills, applying (Q)SAR methodologies to support hazard and environmental endpoint assessment. She is proficient in a range of regulatory modelling tools, including ECOSAR, EPI Suite, KREATiS iSafeRat®, the OECD (Q)SAR Toolbox, and the Danish (Q)SAR Toolbox, strengthening scientific weight-of-evidence approaches in regulatory submissions.
Keyu holds a BSc (Hons) in Pharmaceutics from Shenyang Pharmaceutical University and an MSc in Medicinal and Biological Chemistry from the University of Edinburgh. Her academic background includes extensive experience in medicinal chemistry, chromatography, and laboratory data analysis. During her postgraduate research, she designed and synthesised a supramolecular metallacage with potential applications as both a catalytic system and an in vivo delivery platform, demonstrating strong scientific and analytical capabilities that underpin her regulatory work.
